CMS Medicare Drug Coverage Fraud Alerts

被引:0
|
作者
Gingerich, Barbara Stover [1 ,2 ]
机构
[1] Advantage Consultants Inc, Orlando, FL 32806 USA
[2] York Coll Penn, Dept Nursing, York, PA USA
来源
关键词
drug; Medicare; prescription; marketing; fraud; prevention;
D O I
10.1177/1084822305284745
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
These proactive preventative steps seemed to herald a new approach to fraud and abuse detection. This new approach allowed the expansion of the core efforts of government agencies to other partnering groups and organizations to detect, report, investigate, and refer findings. This provides for increased monitoring from diverse fronts and increases scrutiny of the health care provider industry as a whole. From a home care and hospice prospective, it is important that we understand what prescription drug plans are allowed and not allowed to market and promote to the Medicare beneficiary. It is also important that we know the parameters of any allowable telemarketing from companies offering prescription drug plans and that we be able to assist our patients in adding their telephone numbers to the Do Not Call lists. In regard to privacy and inappropriate use of personal information, there are several telephone numbers to have available for use. They are: • Medicare Beneficiaries Contact - (800) MEDICARE or (800) 633-4227 • The Federal Trade Commission's ID Theft Hotline - (866) 653-4261 These numbers can prove useful for other concerns, not just those relating to the Medicare prescription drug benefit. It is also important that home care and hospice providers acquire an understanding of how the more basic Medicare Part D plans are structured and be able to at a minimum assist Medicare beneficiaries in contacting plans. In regard to hospice care provision and reimbursement, it is also important to realize that this new prescription drug plan is separate from and does not affect those medications included as part of the hospice patient's hospice election drug benefit. And as always, providers should understand and learn from the directions taken by CMS pertaining to one program area in that successful activities and efforts are then often replicated in other arenas. © 2006 Sage Publications.
引用
收藏
页码:408 / 409
页数:2
相关论文
共 50 条
  • [21] Sources of Drug Coverage among Medicare Beneficiaries with ESRD
    Howell, Benjamin L.
    Powers, Christopher A.
    Weinhandl, Eric D.
    St Peter, Wendy L.
    Frankenfield, Diane L.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (05): : 959 - 965
  • [22] Medicare coverage boosts interest in drug value, prices
    Wechsler, J
    FORMULARY, 2004, 39 (05) : 269 - 270
  • [23] Estimating the effects of prescription drug coverage for medicare beneficiaries
    Shea, Dennis G.
    Terza, Joseph V.
    Stuart, Bruce C.
    Briesacher, Becky
    HEALTH SERVICES RESEARCH, 2007, 42 (03) : 933 - 949
  • [24] Medicare prescription drug coverage: Consumer information and preferences
    Winter, Joachim
    Balzal, Rowilma
    Caro, Frank
    Heiss, Florian
    Jun, Byung-hill
    Matzkin, Rosa
    McFadden, Daniel
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (20) : 7929 - 7934
  • [25] Medicare fraud and abuse
    Smirnow, V
    DIALYSIS & TRANSPLANTATION, 1997, 26 (10) : 706 - &
  • [26] Combating Medicare Fraud
    Mitka, Mike
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (22): : 2317 - 2317
  • [27] MEDICARE FRAUD AND ABUSE
    MATHEWS, CL
    JOURNAL OF THE MISSISSIPPI STATE MEDICAL ASSOCIATION, 1977, 18 (05): : 127 - 127
  • [28] Prescription drug coverage and effects on drug expenditures among elderly medicare beneficiaries
    Huh, Soonim
    Rice, Thomas
    Ettner, Susan L.
    HEALTH SERVICES RESEARCH, 2008, 43 (03) : 810 - 832
  • [29] EFFECTS OF MEDICARE PRESCRIPTION DRUG COVERAGE ON NON-DRUG MEDICAL SPENDING
    McWilliams, J. Michael
    Zaslavsky, Alan M.
    Huskamp, Haiden A.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2011, 26 : S157 - S157
  • [30] Drug Coverage and Decision Making in Medicare Part D Enrollees
    Hales, John W.
    Mills, Karmardi
    Hegamin, Angela P.
    Poulios, Nick S.
    AMERICAN JOURNAL OF PHARMACY BENEFITS, 2011, 3 (04) : 221 - 228